Table 4

Median methylation levels of NKX2-5, HAND1, and TBX20 in the TOF patients and controls
Gene TOF (median, IQR1) Control (median, IQR) P2
HAND1 30.5%, 20.8%–40.9%, n = 30 18.7%, 12.2%–24.8%, n =15 0.0006
TBX20 16.2%, 11.0%–24.1%, n =31 29.5%, 25.0%–38.9%, n =13 <0.0001
NKX2-5 30.5%, 18.4%–43.4%, n =25 20.0%, 13.6%–23.2%, n =13 0.018

1IQR: interquartile range; 2Mann-Whitney U test was used.

Sheng et al.

Sheng et al. BMC Medical Genomics 2012 5:20   doi:10.1186/1755-8794-5-20

Open Data